A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration

NCT04594681 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

116

Enrollment

INDUSTRY

Sponsor class

Stopped The Sponsor judged that the objectives of this Phase 1 study were satisfied, and the study was terminated after the completion of Cohort 3 Step 3.

Conditions

Healthy Volunteers
Wet Age-related Macular Degeneration

Interventions

DRUG: Placebo
DRUG: KHK4951

Sponsor

Kyowa Kirin Co., Ltd.